Antiseptic Skin Agents to Prevent Surgical Site Infection After Incisional Surgery

医学 置信区间 防腐剂 洗必泰 随机对照试验 不利影响 外科 内科学 牙科 病理
作者
Stephen R. Smith,Jon Gani,R. Carroll,Natalie Lott,Jacob Hampton,Christopher Oldmeadow,Mathew Clapham,John Attia
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:275 (5): 842-848 被引量:8
标识
DOI:10.1097/sla.0000000000005244
摘要

To compare SSI rates between the skin preparation agents: PI-Aq, povidone-iodine with alcohol (PI-Alc), and chlorhexidine with alcohol (C-Alc).Guidelines suggest that alcohol-containing chlorhexidine solutions are the gold standard for skin preparation before surgery. It remains difficult to determine whether it is the chlorhexidine component or the addition of alcohol that confers the most benefit.We conducted a multicenter, prospective, combined non-inferiority (PI-Alc vs C-Alc) and superiority (PI-Alc vs PI-Aq) randomized clinical trial. Participants were randomized 1:1:1 to receive either C-Alc, PI-Alc, or PI-Aq. The primary outcome was SSI rate as defined by the Centers for Disease Control. Secondary outcomes were complication rates, length of hospital stay, readmissions, and skin reactions.Between January 2015 and December 2018, 3213 patients were randomized (C-Alc: 1076, PI-Alc: 1075, and PI-Aq: 1062). Mean age of participants was 57% and 55% were female. SSI rates were: C-Alc 11.09%, PI-Alc 10.88%, and PI-Aq 12.56%. PI-Alc was found to be non-inferior to C-Alc (mean difference, -0.21%; 95% confidence interval, -2.85 to 2.44; P = 0.0009 non-inferiority), whereas PI-Alc was not superior to PI-Aq (mean difference, -1.68%; 95% confidence interval, -4.40 to 1.05; P = 0.2302). There were no differences seen in secondary outcomes between groups and no treatment related adverse events or deaths occurred.PI-Alc is non-inferior to C-Alc and not superior to PI-Aq. This is at odds with current guidelines that suggest alcohol-based chlorhexidine solutions should routinely be used for surgical skin preparation.Australia and New Zealand Clinical Trials Registry: ANZCTRN12615000021571. www.anzctr.org.au.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
CodeCraft应助柳絮采纳,获得10
刚刚
刚刚
整齐冬瓜完成签到,获得积分10
1秒前
完美世界应助凤凰山采纳,获得10
1秒前
粱自中发布了新的文献求助10
1秒前
1秒前
无花果应助孟陬十一采纳,获得10
2秒前
NEMO完成签到,获得积分20
2秒前
2秒前
2秒前
没有昵称完成签到,获得积分10
3秒前
3秒前
充电宝应助屹舟采纳,获得10
3秒前
3秒前
大胆的莛发布了新的文献求助10
3秒前
Akim应助caicai采纳,获得10
3秒前
科研通AI5应助俏皮的悟空采纳,获得30
4秒前
++完成签到 ,获得积分10
4秒前
星星完成签到,获得积分10
5秒前
脑洞疼应助bioinforiver采纳,获得80
5秒前
ZL发布了新的文献求助10
5秒前
111完成签到,获得积分10
5秒前
沐风完成签到,获得积分20
5秒前
6秒前
CipherSage应助澹台灭明采纳,获得10
6秒前
Oreaee完成签到,获得积分10
7秒前
fanfanzzz完成签到,获得积分10
7秒前
英姑应助MADKAI采纳,获得10
7秒前
mammoth发布了新的文献求助20
7秒前
7秒前
大个应助唉呦嘿采纳,获得10
8秒前
9秒前
Jenny应助觅桃乌龙采纳,获得10
9秒前
JL完成签到,获得积分10
10秒前
10秒前
123完成签到,获得积分10
10秒前
赘婿应助eric曾采纳,获得10
11秒前
11秒前
善学以致用应助小虎采纳,获得30
11秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527742
求助须知:如何正确求助?哪些是违规求助? 3107867
关于积分的说明 9286956
捐赠科研通 2805612
什么是DOI,文献DOI怎么找? 1540026
邀请新用户注册赠送积分活动 716884
科研通“疑难数据库(出版商)”最低求助积分说明 709762